Sponsor: 
GlaxoSmithKline Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Combination vaccines

Registered for primary immunisation in infants aged 6 weeks–12 months.

Hib-MenC — combination Haemophilus influenzae type b and meningococcal serogroup C–tetanus toxoid conjugate vaccine

Lyophilised powder in a monodose vial with a pre-filled diluent syringe.

Each 0.5 mL reconstituted dose contains:

  • 5 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 12.5 µg tetanus toxoid (PRP-T)
  • 5 µg Neisseria meningitidis serogroup C polysaccharide conjugated to 5 µg tetanus toxoid
  • traces of trometamol

For full details, refer to the product information and consumer medicine information sheets for Menitorix vaccine available on the TGA website.

Previous

Menactra

Next

Menveo

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

PRP
polyribosylribitol phosphate